Literature DB >> 2652283

[The transformation of Basedow's struma into nodular goiter: a reason for recurrence of hyperthyroidism].

H Studer1, G Huber, M Derwahl, P Frey.   

Abstract

Graves' disease is characterized by a diffuse and homogeneously hyperfunctioning goiter, presumably caused by thyroid stimulating, TSH-receptor directed antibodies (TRAB). However, in many patients the serum concentration of TRAB is in no way parallel to the severity of the clinical course of Graves' hyperthyroidism. In particular, hyperthyroidism may persist or repeatedly relapse over many years despite the absence of high TRAB titers. The present study summarizes the existing evidence that this course of Graves' disease may be due to gradually evolving autonomously growing and functioning micro- or macronodules within the originally diffuse goiter.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2652283

Source DB:  PubMed          Journal:  Schweiz Med Wochenschr        ISSN: 0036-7672


  5 in total

Review 1.  Molecular pathogenesis of nodular goiter.

Authors:  Ralf Paschke
Journal:  Langenbecks Arch Surg       Date:  2011-04-14       Impact factor: 3.445

2.  [Occurrence of immune hyperthyroidism after radioiodine therapy of autonomous goiter].

Authors:  C Hirsch; J L Spyra; H R Langhammer; C Laubenbacher; R Senekowitsch-Schmidtke; M Schwaiger
Journal:  Med Klin (Munich)       Date:  1997-03-15

3.  A reappraisal of the role of methimazole and other factors on the efficacy and outcome of radioiodine therapy of Graves' hyperthyroidism.

Authors:  C Marcocci; D Gianchecchi; I Masini; F Golia; C Ceccarelli; E Bracci; G F Fenzi; A Pinchera
Journal:  J Endocrinol Invest       Date:  1990-06       Impact factor: 4.256

Review 4.  The Marine-Lenhart syndrome revisited.

Authors:  Hans-Jürgen Biersack; Kim Biermann
Journal:  Wien Klin Wochenschr       Date:  2011-07-27       Impact factor: 2.275

5.  Serum 8-OHdG and HIF-1α levels: do they affect the development of malignancy in patients with hypoactive thyroid nodules?

Authors:  Harman Ece; Erdogan Mehmet; Biray Avci Cigir; Dodurga Yavuz; Karadeniz Muammer; Gunduz Cumhur; Harman Mustafa; Cetinkalp Sevki; Saygılı Fusun; Ozgen Ahmet Gokhan
Journal:  Contemp Oncol (Pozn)       Date:  2013-03-15
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.